Department of Nuclear Medicine, University Hospital Freiburg, Freiburg, Germany.
Neuroimage. 2010 Apr 15;50(3):984-93. doi: 10.1016/j.neuroimage.2010.01.037. Epub 2010 Jan 18.
[(11)C]MDL100,907 is a promising positron emission tomography (PET) ligand for 5-HT(2A) receptor quantification in vivo. Studies suggest that [(11)C]MDL100,907 PET may be quantified by non-invasive reference tissue analyses using cerebellum as reference region. We systematically investigated the validity of such analyses.
Five healthy volunteers underwent [(11)C]MDL100,907 PET at baseline and after mirtazapine pre-treatment. Regional time-activity curves of 10 regions of interest (ROI) were analyzed for binding potential (BP(ND)) and mirtazapine receptor occupancy (Occ) using: simplified reference tissue model (SRTM), multi-linear reference tissue model (MRTM), their two-parameter versions (SRTM2/MRTM2), non-invasive graphical analysis (NIGA) and a tissue activity concentration ratio. NIGA was also applied voxel-wise to generate BP(ND) maps. These methods were compared with a two-tissue compartment model with arterial input function (2TCM) Results: SRTM and MRTM frequently failed to yield reliable results. SRTM2 and MRTM2 gave virtually identical estimates of BP(ND), which were highly correlated with 2TCM analyses (R(2)>or=0.86) although with negative bias (-29+/-27% at baseline across all ROI). NIGA was less biased (-19+/-16%) and better correlated with 2TCM (R(2)>or=0.93). Regarding Occ, NIGA and SRTM2/MRTM2 showed comparable mean biases (-11+/-27% vs. -7+/-47%) but correlation with 2TCM was higher for NIGA (R(2)=0.90 vs. 0.77). NIGA parametric maps (analysed using identical ROI) resulted in moderate bias in BP(ND) (-26+/-22%; R(2)>or=0.88) and Occ (-17+/-36%; R(2)=0.78). Estimates obtained from tissue ratios performed least favourably.
NIGA is well suited for analysis of [(11)C]MDL100,907 PET studies, yielding estimates of 5-HT(2A) receptor availability and changes that are highly correlated with results from invasive 2TCM analyses. This should greatly enhance the applicability of 5-HT(2A) receptor PET studies.
[(11)C]MDL100,907 是一种有前途的正电子发射断层扫描 (PET) 配体,可用于体内 5-羟色胺 (5-HT)2A 受体定量。研究表明,[(11)C]MDL100,907 PET 可通过使用小脑作为参考区域的非侵入性参考组织分析进行定量。我们系统地研究了这种分析的有效性。
五名健康志愿者在基线和米氮平预处理后进行 [(11)C]MDL100,907 PET 扫描。使用简化参考组织模型 (SRTM)、多线性参考组织模型 (MRTM)、其双参数版本 (SRTM2/MRTM2)、非侵入性图形分析 (NIGA) 和组织活性浓度比分析 10 个感兴趣区 (ROI) 的区域时间-活性曲线,以获得结合潜力 (BP(ND)) 和米氮平受体占有率 (Occ)。NIGA 还用于生成 BP(ND) 图的体素分析。这些方法与带有动脉输入函数的两组织室模型 (2TCM) 进行了比较。
SRTM 和 MRTM 经常无法得出可靠的结果。SRTM2 和 MRTM2 几乎可以提供相同的 BP(ND) 估计值,与 2TCM 分析高度相关 (R(2)>0.86),尽管存在负偏差 (-29+/-27%,所有 ROI 的基线值)。NIGA 的偏差较小 (-19+/-16%),与 2TCM 的相关性更好 (R(2)>0.93)。关于 Occ,NIGA 和 SRTM2/MRTM2 显示出相似的平均偏差 (-11+/-27% 与 -7+/-47%),但 NIGA 与 2TCM 的相关性更高 (R(2)=0.90 与 0.77)。使用相同 ROI 分析的 NIGA 参数量图导致 BP(ND) 的中度偏差 (-26+/-22%; R(2)>0.88)和 Occ (-17+/-36%; R(2)=0.78)。从组织比获得的估计值表现最差。
NIGA 非常适合 [(11)C]MDL100,907 PET 研究的分析,可提供 5-HT(2A) 受体可用性的估计值,并且与侵入性 2TCM 分析的结果高度相关。这将极大地增强 5-HT(2A) 受体 PET 研究的适用性。